HemoCue AB - Point of Care Diagnostic Products

• Tel: +46 431 45 82 00
• Contact this Company »
• Visit Web Site »

Subscribe

HemoCue AB develops, produces, and markets medical diagnostic products for point-of-care testing.

The fundamental concept behind the HemoCue products is to perform common blood tests at the point-of-care without sacrificing the accuracy and precision offered by a central clinical lab.

Unique Cuvette Technology

The two inventors of the HemoCue system, Sven-Erik Nilsson and Jan Lilja started the work with the cuvette concept already in 1974. Still, our systems are based on patented cuvette technology, unique reagent chemistry and analyte-specific instruments. The systems do not require mixing of reagents, dispensing, or pipetting.

The instruments are factory-calibrated and all cuvettes are produced such that no adjustment for batch-to-batch variation is necessary. With a minimum of product training and instrument maintenance, this makes it possible also for staff without laboratory training to consistently perform tests yielding accurate results.

B-Hemoglobin and B-Glucose Instruments

The HemoCue B-Hemoglobin system was introduced in the early 1980s. The HemoCue B-Glucose system was introduced on a worldwide basis in the beginning of the 1990s. Since the introduction, we have installed almost 200,000 B-Hemoglobin and B-Glucose instruments globally.

Public Healthcare Screening

HemoCue is a company with few products, but many customers and market segments. Blood banks, medical offices in primary care, public healthcare screening programs, critical care departments in hospitals (emergency rooms, neonatal and adult intensive care units, operating rooms and post-operative care), dialysis clinics, diabetes clinics and outpatient surgery centers, all require tests for hemoglobin, glucose, or both.

Preventaitive Health Care

Since December 1999, HemoCue is owned by EQT (www.eqt.se). The HemoCue product line is sold in more than 120 countries through a highly effective organisation consisting of independent distributor partners and subsidiaries.

HemoCue is a company that has developed a keen sensitivity for the needs of customers in primary health care settings and a focus on preventative health care opportunities. Given current global trends in these areas, we are convinced our products will continue to provide valuable opportunities on a world wide basis, for a long time to come.

HemoCue AB
Box 1204
SE-262 23 Angelholm
Sweden

Tel: +46 431 45 83 11
Fax: +46 431 45 82 25

Web: www.hemocue.com

Diabetes

• 42nd Annual Meeting of the European Association for the Study of Diabetes »
  HemoCue will arrange a symposium "Prediction and monitoring of cardiovascular and renal risk in diabetes".
  
  

Data Management Systems

• 201 Data Management Systems »
  HemoCue introduces point-of-care testing (POCT) devices with advanced Data Management capabilities.
  
  

Albuminuria

• HemoCue Albuminuria »
  The HemoCue Albumin systems can be used for the quantitative determination of low levels of albumin in urine for the purpose of screening for, diagnosing, monitoring and supporting the clinical evidence in the treatment of microalbuminuria.